{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["DNA adducts", "HSA-ligand interactions", "X-ray crystallography", "aristolochic acids", "bioactivation", "environmental carcinogens", "fluorescence spectroscopy", "isothermal titration calorimetry"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38782206", "DateCompleted": {"Year": "2024", "Month": "07", "Day": "25"}, "DateRevised": {"Year": "2024", "Month": "07", "Day": "25"}, "Article": {"Language": ["eng"], "ELocationID": ["107358", "10.1016/j.jbc.2024.107358", "S0021-9258(24)01859-3"], "ArticleDate": [{"Year": "2024", "Month": "05", "Day": "22"}], "Journal": {"ISSN": "1083-351X", "JournalIssue": {"Volume": "300", "Issue": "7", "PubDate": {"Year": "2024", "Month": "Jul"}}, "Title": "The Journal of biological chemistry", "ISOAbbreviation": "J Biol Chem"}, "ArticleTitle": "Structural and mechanistic insights into the transport of aristolochic acids and their active metabolites by human serum albumin.", "Pagination": {"StartPage": "107358", "MedlinePgn": "107358"}, "Abstract": {"AbstractText": ["Aristolochic acids I and II (AA-I/II) are carcinogenic principles of Aristolochia plants, which have been employed in traditional medicinal practices and discovered as food contaminants. While the deleterious effects of AAs are broadly acknowledged, there is a dearth of information to define the mechanisms underlying their carcinogenicity. Following bioactivation in the liver, N-hydroxyaristolactam and N-sulfonyloxyaristolactam metabolites are transported via circulation and elicit carcinogenic effects by reacting with cellular DNA. In this study, we apply DNA adduct analysis, X-ray crystallography, isothermal titration calorimetry, and fluorescence quenching to investigate the role of human serum albumin (HSA) in modulating AA carcinogenicity. We find that HSA extends the half-life and reactivity of N-sulfonyloxyaristolactam-I with DNA, thereby protecting activated AAs from heterolysis. Applying novel pooled plasma HSA crystallization methods, we report high-resolution structures of myristic acid-enriched HSA (HSA<sub>MYR</sub>) and its AA complexes (HSA<sub>MYR</sub>/AA-I and HSA<sub>MYR</sub>/AA-II) at 1.9\u00a0\u00c5 resolution. While AA-I is located within HSA subdomain IB, AA-II occupies subdomains IIA and IB. ITC binding profiles reveal two distinct AA sites in both complexes with association constants of 1.5 and 0.5 \u00b7 10<sup>6</sup>\u00a0M<sup>-1</sup> for HSA/AA-I versus 8.4 and 9.0 \u00b7 10<sup>5</sup>\u00a0M<sup>-1</sup> for HSA/AA-II. Fluorescence quenching of the HSA Trp<sup>214</sup> suggests variable impacts of fatty acids on ligand binding affinities. Collectively, our structural and thermodynamic characterizations yield significant insights into AA binding, transport, toxicity, and potential allostery, critical determinants for elucidating the mechanistic roles of HSA in modulating AA carcinogenicity."], "CopyrightInformation": "Copyright \u00a9 2024 The Authors. Published by Elsevier Inc. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem, Israel."}], "LastName": "Pomyalov", "ForeName": "Sergei", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry and Chemical Biology, Rutgers - The State University of New Jersey, Piscataway, New Jersey, USA."}], "LastName": "Minetti", "ForeName": "Concei\u00e7\u00e3o A", "Initials": "CA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry and Chemical Biology, Rutgers - The State University of New Jersey, Piscataway, New Jersey, USA."}], "LastName": "Remeta", "ForeName": "David P", "Initials": "DP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacological Sciences, Stony Brook University, Stony Brook, New York, USA."}], "LastName": "Bonala", "ForeName": "Radha", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacological Sciences, Stony Brook University, Stony Brook, New York, USA; Department of Chemistry, Stony Brook University, Stony Brook, New York, USA."}], "LastName": "Johnson", "ForeName": "Francis", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacological Sciences, Stony Brook University, Stony Brook, New York, USA."}], "LastName": "Zaitseva", "ForeName": "Irina", "Initials": "I"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacological Sciences, Stony Brook University, Stony Brook, New York, USA."}], "LastName": "Iden", "ForeName": "Charles", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, Stony Brook University, Stony Brook, New York, USA; Department of Biological Sciences, Queensborough Community College, Bayside, New York, USA."}], "LastName": "Golebiewska", "ForeName": "Urszula", "Initials": "U"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry and Chemical Biology, Rutgers - The State University of New Jersey, Piscataway, New Jersey, USA; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA. Electronic address: kjbdna@rutgers.edu."}], "LastName": "Breslauer", "ForeName": "Kenneth J", "Initials": "KJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem, Israel. Electronic address: gil2@mail.huji.ac.il."}], "LastName": "Shoham", "ForeName": "Gil", "Initials": "G"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacological Sciences, Stony Brook University, Stony Brook, New York, USA. Electronic address: viktoriya.sidorenko@nih.gov."}], "LastName": "Sidorenko", "ForeName": "Viktoriya S", "Initials": "VS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacological Sciences, Stony Brook University, Stony Brook, New York, USA. Electronic address: arthur.grollman@stonybrook.edu."}], "LastName": "Grollman", "ForeName": "Arthur P", "Initials": "AP"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Biol Chem", "NlmUniqueID": "2985121R", "ISSNLinking": "0021-9258"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Aristolochic Acids"}, {"RegistryNumber": "ZIF514RVZR", "NameOfSubstance": "Serum Albumin, Human"}, {"RegistryNumber": "0", "NameOfSubstance": "DNA Adducts"}, {"RegistryNumber": "94218WFP5T", "NameOfSubstance": "aristolochic acid I"}, {"RegistryNumber": "0I3V7S25AW", "NameOfSubstance": "Myristic Acid"}, {"RegistryNumber": "BB72D5PU2Y", "NameOfSubstance": "aristolochic acid II"}], "MeshHeadingList": [{"QualifierName": ["metabolism", "chemistry"], "DescriptorName": "Aristolochic Acids"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Crystallography, X-Ray"}, {"QualifierName": ["metabolism", "chemistry"], "DescriptorName": "Serum Albumin, Human"}, {"QualifierName": ["metabolism", "chemistry"], "DescriptorName": "DNA Adducts"}, {"QualifierName": [], "DescriptorName": "Protein Binding"}, {"QualifierName": ["metabolism", "chemistry"], "DescriptorName": "Myristic Acid"}], "CoiStatement": "Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Beutler J.A. Natural products as a foundation for drug discovery. Curr. Protoc. Pharmacol. 2019;86", "ArticleIdList": ["PMC7442317", "31539923"]}, {"Citation": "Katz L., Baltz R.H. Natural product discovery: past, present, and future. J.\u00a0Ind. Microbiol. Biotechnol. 2016;43:155\u2013176.", "ArticleIdList": ["26739136"]}, {"Citation": "Grollman A.P., Marcus D.M. Global hazards of herbal remedies: lessons from aristolochia: the lesson from the health hazards of aristolochia should lead to more research into the safety and efficacy of medicinal plants. EMBO Rep. 2016;17:619\u2013625.", "ArticleIdList": ["PMC5341512", "27113747"]}, {"Citation": "Grollman A.P. Aristolochic acid nephropathy: harbinger of a global iatrogenic disease. Environ. Mol. Mutagen. 2013;54:1\u20137.", "ArticleIdList": ["23238808"]}, {"Citation": "Kumar V., Poonam, Prasad A.K., Parmar V.S. Naturally occurring aristolactams, aristolochic acids and dioxoaporphines and their biological activities. Nat. Prod. Rep. 2003;20:565\u2013583.", "ArticleIdList": ["14700200"]}, {"Citation": "Michl J., Ingrouille M.J., Simmonds M.S., Heinrich M. Naturally occurring aristolochic acid analogues and their toxicities. Nat. Prod. Rep. 2014;31:676\u2013693.", "ArticleIdList": ["24691743"]}, {"Citation": "Bunel V., Souard F., Antoine M.-H., Stevigny C., Nortier J.L. In: Comprehensive Toxicology, Second Edition. McQueen C.A., editor. Academic Press; Oxford: 2017. This is an update of Dickman, K.G., Grollman, A.P., Nephrotoxicity of natural products: aristolochic acid and fungal toxins (2010) pp. 433\u2013458."}, {"Citation": "Shibutani S., Dong H., Suzuki N., Ueda S., Miller F., Grollman A.P. Selective toxicity of aristolochic acids I and II. Drug Metab. Dispos. 2007;35:1217\u20131222.", "ArticleIdList": ["17392392"]}, {"Citation": "Nortier J.L., Martinez M.C., Schmeiser H.H., Arlt V.M., Bieler C.A., Petein M., et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi) N.\u00a0Engl. J. Med. 2000;342:1686\u20131692.", "ArticleIdList": ["10841870"]}, {"Citation": "Vanherweghem J.L., Depierreux M., Tielemans C., Abramowicz D., Dratwa M., Jadoul M., et al. Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet. 1993;341:387\u2013391.", "ArticleIdList": ["8094166"]}, {"Citation": "Vanherweghem L.J. Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy) J.\u00a0Altern. Complement. Med. 1998;4:9\u201313.", "ArticleIdList": ["9553830"]}, {"Citation": "Chen C.H., Dickman K.G., Moriya M., Zavadil J., Sidorenko V.S., Edwards K.L., et al. Aristolochic acid-associated urothelial cancer in Taiwan. Proc. Natl. Acad. Sci. U. S. A. 2012;109:8241\u20138246.", "ArticleIdList": ["PMC3361449", "22493262"]}, {"Citation": "Hoang M.L., Chen C.H., Sidorenko V.S., He J., Dickman K.G., Yun B.H., et al. Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing. Sci. Transl. Med. 2013;5", "ArticleIdList": ["PMC3973132", "23926200"]}, {"Citation": "Chen C.H., Grollman A.P., Huang C.Y., Shun C.T., Sidorenko V.S., Hashimoto K., et al. Additive effects of arsenic and aristolochic acid in chemical carcinogenesis of upper urinary tract urothelium. Cancer Epidemiol. Biomarkers Prev. 2021;30:317\u2013325.", "ArticleIdList": ["PMC8083126", "33277322"]}, {"Citation": "Grollman A.P., Shibutani S., Moriya M., Miller F., Wu L., Moll U., et al. Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc. Natl. Acad. Sci. U. S. A. 2007;104:12129\u201312134.", "ArticleIdList": ["PMC1913550", "17620607"]}, {"Citation": "Hoang M.L., Chen C.H., Chen P.C., Roberts N.J., Dickman K.G., Yun B.H., et al. Aristolochic acid in the etiology of renal cell carcinoma. Cancer Epidemiol. Biomarkers Prev. 2016;25:1600\u20131608.", "ArticleIdList": ["PMC5533284", "27555084"]}, {"Citation": "Scelo G., Riazalhosseini Y., Greger L., Letourneau L., Gonzalez-Porta M., Wozniak M.B., et al. Variation in genomic landscape of clear cell renal cell carcinoma across Europe. Nat. Commun. 2014;5:5135.", "ArticleIdList": ["25351205"]}, {"Citation": "Turesky R.J., Yun B.H., Brennan P., Mates D., Jinga V., Harnden P., et al. Aristolochic acid exposure in Romania and implications for renal cell carcinoma. Br. J. Cancer. 2016;114:76\u201380.", "ArticleIdList": ["PMC4716534", "26657656"]}, {"Citation": "Jelakovic B., Castells X., Tomic K., Ardin M., Karanovic S., Zavadil J. Renal cell carcinomas of chronic kidney disease patients harbor the mutational signature of carcinogenic aristolochic acid. Int. J. Cancer. 2015;136:2967\u20132972.", "ArticleIdList": ["PMC4720973", "25403517"]}, {"Citation": "Castells X., Karanovic S., Ardin M., Tomic K., Xylinas E., Durand G., et al. Low-coverage exome sequencing screen in formalin-fixed paraffin-embedded tumors reveals evidence of exposure to carcinogenic aristolochic acid. Cancer Epidemiol. Biomarkers Prev. 2015;24:1873\u20131881.", "ArticleIdList": ["PMC4806408", "26383547"]}, {"Citation": "Poon S.L., Huang M.N., Choo Y., McPherson J.R., Yu W., Heng H.L., et al. Mutation signatures implicate aristolochic acid in bladder. Cancer Dev. Genome Med. 2015;7:38.", "ArticleIdList": ["PMC4443665", "26015808"]}, {"Citation": "Poon S.L., Pang S.T., McPherson J.R., Yu W., Huang K.K., Guan P., et al. Genome-wide mutational signatures of aristolochic acid and its application as a screening tool. Sci. Transl. Med. 2013;5", "ArticleIdList": ["23926199"]}, {"Citation": "Totoki Y., Tatsuno K., Covington K.R., Ueda H., Creighton C.J., Kato M., et al. Trans-ancestry mutational landscape of hepatocellular carcinoma genomes. Nat. Genet. 2014;46:1267\u20131273.", "ArticleIdList": ["25362482"]}, {"Citation": "Ng A.W.T., Poon S.L., Huang M.N., Lim J.Q., Boot A., Yu W., et al. Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia. Sci. Transl. Med. 2017;9", "ArticleIdList": ["29046434"]}, {"Citation": "Jusakul A., Cutcutache I., Yong C.H., Lim J.Q., Huang M.N., Padmanabhan N., et al. Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma. Cancer Discov. 2017;7:1116\u20131135.", "ArticleIdList": ["PMC5628134", "28667006"]}, {"Citation": "Zou S., Li J., Zhou H., Frech C., Jiang X., Chu J.S., et al. Mutational landscape of intrahepatic cholangiocarcinoma. Nat. Commun. 2014;5:5696.", "ArticleIdList": ["25526346"]}, {"Citation": "Rosenquist T.A., Grollman A.P. Mutational signature of aristolochic acid: clue to the recognition of a global disease. DNA Repair. 2016;44:205\u2013211.", "ArticleIdList": ["27237586"]}, {"Citation": "Das S., Thakur S., Korenjak M., Sidorenko V.S., Chung F.F., Zavadil J. Aristolochic acid-associated cancers: a public health risk in need of global action. Nat. Rev. Cancer. 2022;22:576\u2013591.", "ArticleIdList": ["35854147"]}, {"Citation": "Minetti C.A.S.A., Remeta D.P., Johnson F., Iden C.R., Breslauer K.J. Impact of alpha-hydroxy-propanodeoxyguanine adducts on DNA duplex energetics: opposite base modulation and implications for mutagenicity and genotoxicity. Biopolymers. 2010;93:370\u2013382.", "ArticleIdList": ["PMC2891022", "19937758"]}, {"Citation": "Schmeiser H.H., Bieler C.A., Wiessler M., van Ypersele de Strihou C., Cosyns J.P. Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Res. 1996;56:2025\u20132028.", "ArticleIdList": ["8616845"]}, {"Citation": "Arlt V.M., Stiborova M., vom Brocke J., Simoes M.L., Lord G.M., Nortier J.L., et al. Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer. Carcinogenesis. 2007;28:2253\u20132261.", "ArticleIdList": ["17434925"]}, {"Citation": "Hollstein M., Moriya M., Grollman A.P., Olivier M. Analysis of TP53 mutation spectra reveals the fingerprint of the potent environmental carcinogen, aristolochic acid. Mutat. Res. 2013;753:41\u201349.", "ArticleIdList": ["PMC3689860", "23422071"]}, {"Citation": "Nedelko T., Arlt V.M., Phillips D.H., Hollstein M. TP53 mutation signature supports involvement of aristolochic acid in the aetiology of endemic nephropathy-associated tumours. Int. J. Cancer. 2009;124:987\u2013990.", "ArticleIdList": ["19030178"]}, {"Citation": "Attaluri S., Bonala R.R., Yang I.Y., Lukin M.A., Wen Y., Grollman A.P., et al. DNA adducts of aristolochic acid II: total synthesis and site-specific mutagenesis studies in mammalian cells. Nucleic Acids Res. 2010;38:339\u2013352.", "ArticleIdList": ["PMC2800210", "19854934"]}, {"Citation": "Sidorenko V.S., Yeo J.E., Bonala R.R., Johnson F., Scharer O.D., Grollman A.P. Lack of recognition by global-genome nucleotide excision repair accounts for the high mutagenicity and persistence of aristolactam-DNA adducts. Nucleic Acids Res. 2012;40:2494\u20132505.", "ArticleIdList": ["PMC3315299", "22121226"]}, {"Citation": "Sidorenko V.S. Biotransformation and toxicities of aristolochic acids. Adv. Exp. Med. Biol. 2020;1241:139\u2013166.", "ArticleIdList": ["32383120"]}, {"Citation": "Arlt V.M., Meinl W., Florian S., Nagy E., Barta F., Thomann M., et al. Impact of genetic modulation of SULT1A enzymes on DNA adduct formation by aristolochic acids and 3-nitrobenzanthrone. Arch. Toxicol. 2017;91:1957\u20131975.", "ArticleIdList": ["PMC5364269", "27557898"]}, {"Citation": "Martinek V., Kubickova B., Arlt V.M., Frei E., Schmeiser H.H., Hudecek J., et al. Comparison of activation of aristolochic acid I and II with NADPH:quinone oxidoreductase, sulphotransferases and N-acetyltranferases. Neuro Endocrinol. Lett. 2011;32 Suppl 1:57\u201370.", "ArticleIdList": ["22167209"]}, {"Citation": "Hashimoto K., Zaitseva I.N., Bonala R., Attaluri S., Ozga K., Iden C.R., et al. Sulfotransferase-1A1-dependent bioactivation of aristolochic acid I and N-hydroxyaristolactam I in human cells. Carcinogenesis. 2016;37:647\u2013655.", "ArticleIdList": ["PMC4936383", "27207664"]}, {"Citation": "Sidorenko V.S., Attaluri S., Zaitseva I., Iden C.R., Dickman K.G., Johnson F., et al. Bioactivation of the human carcinogen aristolochic acid. Carcinogenesis. 2014;35:1814\u20131822.", "ArticleIdList": ["PMC4123648", "24743514"]}, {"Citation": "Okuno Y., Bonala R., Attaluri S., Johnson F., Grollman A.P., Sidorenko V.S., et al. Bioactivation mechanisms of N-hydroxyaristolactams: nitroreduction metabolites of aristolochic acids. Environ. Mol. Mutagen. 2019;60:792\u2013806.", "ArticleIdList": ["PMC6899766", "31374128"]}, {"Citation": "Stiborova M., Arlt V.M., Schmeiser H.H. Balkan endemic nephropathy: an update on its aetiology. Arch. Toxicol. 2016;90:2595\u20132615.", "ArticleIdList": ["PMC5065591", "27538407"]}, {"Citation": "Stiborova M., Martinek V., Frei E., Arlt V.M., Schmeiser H.H. Enzymes metabolizing aristolochic acid and their contribution to the development of aristolochic acid nephropathy and urothelial cancer. Curr. Drug Metab. 2013;14:695\u2013705.", "ArticleIdList": ["23701164"]}, {"Citation": "Chang S.Y., Weber E.J., Sidorenko V.S., Chapron A., Yeung C.K., Gao C., et al. Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity. JCI Insight. 2017;2", "ArticleIdList": ["PMC5752374", "29202460"]}, {"Citation": "Priestap H.A., Torres M.C., Rieger R.A., Dickman K.G., Freshwater T., Taft D.R., et al. Aristolochic acid I metabolism in the isolated perfused rat kidney. Chem. Res. Toxicol. 2012;25:130\u2013139.", "ArticleIdList": ["PMC3276251", "22118289"]}, {"Citation": "Dickman K.G., Sweet D.H., Bonala R., Ray T., Wu A. Physiological and molecular characterization of aristolochic acid transport by the kidney. J.\u00a0Pharmacol. Exp. Ther. 2011;338:588\u2013597.", "ArticleIdList": ["PMC3141898", "21546538"]}, {"Citation": "Pfau W., Schmeiser H.H., Wiessler M. 32P-postlabelling analysis of the DNA adducts formed by aristolochic acid I and II. Carcinogenesis. 1990;11:1627\u20131633.", "ArticleIdList": ["2401053"]}, {"Citation": "Bellamri M., Brandt K., Brown C.V., Wu M.T., Turesky R.J. Cytotoxicity and genotoxicity of the carcinogen aristolochic acid I (AA-I) in human bladder RT4 cells. Arch. Toxicol. 2021;95:2189\u20132199.", "ArticleIdList": ["PMC8284306", "33938965"]}, {"Citation": "Smith D.A., Di L., Kerns E.H. The effect of plasma protein binding on in\u00a0vivo efficacy: misconceptions drug discovery. Nat. Rev. Drug Discov. 2010;9:929\u2013939.", "ArticleIdList": ["21119731"]}, {"Citation": "Peters T.J. Academic Press; New York, NY: 1996. All about Albumin: Biochemistry, Genetics, and Medical Applicaitons."}, {"Citation": "Li W., Hu Q., Chan W. Mass spectrometric and spectrofluorometric studies of the interaction of aristolochic acids with proteins. Sci. Rep. 2015;5", "ArticleIdList": ["PMC4608009", "26471474"]}, {"Citation": "Wu X., Liu J., Huang H., Xue W., Yao X., Jin J. Interaction studies of aristolochic acid I with human serum albumin and the binding site of aristolochic acid I in subdomain IIA. Int. J. Biol. Macromol. 2011;49:343\u2013350.", "ArticleIdList": ["21635915"]}, {"Citation": "Peng L., Turesky R.J. Capturing labile sulfenamide and sulfinamide serum albumin adducts of carcinogenic arylamines by chemical oxidation. Anal. Chem. 2013;85:1065\u20131072.", "ArticleIdList": ["PMC3621984", "23240913"]}, {"Citation": "Curry S. Lessons from the crystallographic analysis of small molecule binding to human serum albumin. Drug Metab. Pharmacokinet. 2009;24:342\u2013357.", "ArticleIdList": ["19745561"]}, {"Citation": "Turesky R.J., Skipper P.L., Tannenbaum S.R. Binding of 2-amino-3-methylimidazo[4,5-f]quinoline to hemoglobin and albumin in\u00a0vivo in the rat. Identification of an adduct suitable for dosimetry. Carcinogenesis. 1987;8:1537\u20131542.", "ArticleIdList": ["3652389"]}, {"Citation": "Wang Y., Peng L., Bellamri M., Langouet S., Turesky R.J. Mass spectrometric characterization of human serum albumin adducts formed with N-oxidized metabolites of 2-amino-1-methylphenylimidazo[4,5-b]pyridine in human plasma and hepatocytes. Chem. Res. Toxicol. 2015;28:1045\u20131059.", "ArticleIdList": ["PMC4437839", "25815793"]}, {"Citation": "Zsila F. Subdomain IB is the third major drug binding region of human serum albumin: toward the three-sites model. Mol. Pharm. 2013;10:1668\u20131682.", "ArticleIdList": ["23473402"]}, {"Citation": "Minami T., Terada T., Takahashi T., Arikawa H., Matsuyama Y., Kizaki K., et al. Comparative studies on the heterogeneity of plasma-derived and recombinant human albumins in laboratory use. Int. J. Biol. Macromol. 2014;69:79\u201387.", "ArticleIdList": ["24857876"]}, {"Citation": "Jarmoskaite I., AlSadhan I., Vaidyanathan P.P., Herschlag D. How to measure and evaluate binding affinities. Elife. 2020;9", "ArticleIdList": ["PMC7452723", "32758356"]}, {"Citation": "Brautigam C.A., Zhao H., Vargas C., Keller S., Schuck P. Integration and global analysis of isothermal titration calorimetry data for studying macromolecular interactions. Nat. Protoc. 2016;11:882\u2013894.", "ArticleIdList": ["PMC7466939", "27055097"]}, {"Citation": "Kassaar O., Schwarz-Linek U., Blindauer C.A., Stewart A.J. Plasma free fatty acid levels influence Zn(2+) -dependent histidine-rich glycoprotein-heparin interactions via an allosteric switch on serum albumin. J.\u00a0Thromb. Haemost. 2015;13:101\u2013110.", "ArticleIdList": ["PMC4309485", "25353308"]}, {"Citation": "Menke G., Worner W., Kratzer W., Rietbrock N. Kinetics of drug binding to human serum albumin: allosteric and competitive inhibition at the benzodiazepine binding site by free fatty acids of various chain lengths. Naunyn Schmiedebergs Arch. Pharmacol. 1989;339:42\u201347.", "ArticleIdList": ["2471088"]}, {"Citation": "Fang Y., Tong G.C., Means G.E. Structural changes accompanying human serum albumin's binding of fatty acids are concerted. Biochim. Biophys. Acta. 2006;1764:285\u2013291.", "ArticleIdList": ["16413837"]}, {"Citation": "He Y., Ning T., Xie T., Qiu Q., Zhang L., Sun Y., et al. Large-scale production of functional human serum albumin from transgenic rice seeds. Proc. Natl. Acad. Sci. U. S. A. 2011;108:19078\u201319083.", "ArticleIdList": ["PMC3223471", "22042856"]}, {"Citation": "Bhattacharya A.A., Curry S., Franks N.P. Binding of the general anesthetics propofol and halothane to human serum albumin. High resolution crystal structures. J.\u00a0Biol. Chem. 2000;275:38731\u201338738.", "ArticleIdList": ["10940303"]}, {"Citation": "Fanali G., di Masi A., Trezza V., Marino M., Fasano M., Ascenzi P. Human serum albumin: from bench to bedside. Mol. Aspects Med. 2012;33:209\u2013290.", "ArticleIdList": ["22230555"]}, {"Citation": "Leboffe L., di Masi A., Polticelli F., Trezza V., Ascenzi P. Structural basis of drug recognition by human serum albumin. Curr. Med. Chem. 2020;27:4907\u20134931.", "ArticleIdList": ["30894098"]}, {"Citation": "Franca V.L.B., Amaral J.L., Martins Y.A., Caetano E.W.S., Brunaldi K., Freire V.N. Characterization of the binding interaction between atrazine and human serum albumin: fluorescence spectroscopy, molecular dynamics and quantum biochemistry. Chem. Biol. Interact. 2022;366", "ArticleIdList": ["36037875"]}, {"Citation": "Curry S., Mandelkow H., Brick P., Franks N. Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites. Nat. Struct. Biol. 1998;5:827\u2013835.", "ArticleIdList": ["9731778"]}, {"Citation": "Wardell M., Wang Z.M., Ho J.X., Robert J., Ruker F., Ruble J., et al. The atomic structure of human methemalbumin at 1.9 angstrom. Biochem. Biophys. Res. Commun. 2002;291:813\u2013819.", "ArticleIdList": ["11866438"]}, {"Citation": "Zunszain P.A., Ghuman J., Komatsu T., Tsuchida E., Curry S. Crystal structural analysis of human serum albumin complexed with hemin and fatty acid. BMC Struct. Biol. 2003;3:6.", "ArticleIdList": ["PMC166163", "12846933"]}, {"Citation": "Zhang Y., Lee P., Liang S., Zhou Z., Wu X., Yang F., et al. Structural basis of non-steroidal anti-inflammatory drug diclofenac binding to human serum albumin. Chem. Biol. Drug Des. 2015;86:1178\u20131184.", "ArticleIdList": ["25958880"]}, {"Citation": "Czub M.P., Boulton A.M., Rastelli E.J., Tasker N.R., Maskrey T.S., Blanco I.K., et al. Structure of the complex of an iminopyridinedione protein tyrosine phosphatase 4A3 phosphatase inhibitor with human serum albumin. Mol. Pharmacol. 2020;98:648\u2013657.", "ArticleIdList": ["PMC7658597", "32978326"]}, {"Citation": "Chan C.K., Liu Y., Pavlovic N.M., Chan W. Etiology of Balkan endemic nephropathy: an update on aristolochic acids exposure mechanisms. Chem. Res. Toxicol. 2018;31:1109\u20131110.", "ArticleIdList": ["30346143"]}, {"Citation": "Shibutani S., Bonala R.R., Rosenquist T., Rieger R., Suzuki N., Johnson F., et al. Detoxification of aristolochic acid I by O-demethylation: less nephrotoxicity and genotoxicity of aristolochic acid Ia in rodents. Int. J. Cancer. 2010;127:1021\u20131027.", "ArticleIdList": ["PMC4226239", "20039324"]}, {"Citation": "Bastek H., Zubel T., Stemmer K., Mangerich A., Beneke S., Dietrich D.R. Comparison of aristolochic acid I derived DNA adduct levels in human renal toxicity models. Toxicology. 2019;420:29\u201338.", "ArticleIdList": ["30940547"]}, {"Citation": "Bendadani C., Meinl W., Monien B.H., Dobbernack G., Glatt H. The carcinogen 1-methylpyrene forms benzylic DNA adducts in mouse and rat tissues in\u00a0vivo via a reactive sulphuric acid ester. Arch. Toxicol. 2014;88:815\u2013821.", "ArticleIdList": ["24337722"]}, {"Citation": "Glatt H.M.,W., Kuhlow A., Ma L. Metabolic formation, distribution and toxicological effects of reactive sulfuric acid esters. Nova Acta Leopoldina. 2003;87:11."}, {"Citation": "Ma L., Kuhlow A., Glatt H.R. Albumin strongly prolongs the lifetime of chemically reactive sulphuric esters and affects their biological activities in the rat. Nova Acta Leopoldina. 2003;329:265\u2013272."}, {"Citation": "Minetti C.A., Remeta D.P. Forces driving a magic bullet to its target: revisiting the role of thermodynamics in drug design, development, and optimization. Life. 2022;12:1438.", "ArticleIdList": ["PMC9504344", "36143474"]}, {"Citation": "Zhu L., Yang F., Chen L., Meehan E.J., Huang M. A\u00a0new drug binding subsite on human serum albumin and drug-drug interaction studied by X-ray crystallography. J.\u00a0Struct. Biol. 2008;162:40\u201349.", "ArticleIdList": ["18258455"]}, {"Citation": "Vorum H., Honore B. Influence of fatty acids on the binding of warfarin and phenprocoumon to human serum albumin with relation to anticoagulant therapy. J.\u00a0Pharm. Pharmacol. 1996;48:870\u2013875.", "ArticleIdList": ["8887741"]}, {"Citation": "He X.M., Carter D.C. Atomic structure and chemistry of human serum albumin. Nature. 1992;358:209\u2013215.", "ArticleIdList": ["1630489"]}, {"Citation": "Petitpas I., Bhattacharya A.A., Twine S., East M., Curry S. Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I. J.\u00a0Biol. Chem. 2001;276:22804\u201322809.", "ArticleIdList": ["11285262"]}, {"Citation": "Attaluri S., Iden C.R., Bonala R.R., Johnson F. Total synthesis of the aristolochic acids, their major metabolites, and related compounds. Chem. Res. Toxicol. 2014;27:1236\u20131242.", "ArticleIdList": ["PMC4216193", "24877584"]}, {"Citation": "Riener C.K., Kada G., Gruber H.J. Quick measurement of protein sulfhydryls with Ellman's reagent and with 4,4'-dithiodipyridine. Anal. Bioanal. Chem. 2002;373:266\u2013276.", "ArticleIdList": ["12110978"]}, {"Citation": "Beckett D. Measurement and analysis of equilibrium binding titrations: a beginner's guide. Methods Enzymol. 2011;488:1\u201316.", "ArticleIdList": ["21195222"]}, {"Citation": "Keller S., Vargas C., Zhao H., Piszczek G., Brautigam C.A., Schuck P. High-precision isothermal titration calorimetry with automated peak-shape analysis. Anal. Chem. 2012;84:5066\u20135073.", "ArticleIdList": ["PMC3389189", "22530732"]}, {"Citation": "Bhattacharya A.A., Grune T., Curry S. Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. J.\u00a0Mol. Biol. 2000;303:721\u2013732.", "ArticleIdList": ["11061971"]}, {"Citation": "Zunszain P.A., Ghuman J., McDonagh A.F., Curry S. Crystallographic analysis of human serum albumin complexed with 4Z,15E-bilirubin-IXalpha. J.\u00a0Mol. Biol. 2008;381:394\u2013406.", "ArticleIdList": ["PMC2568863", "18602119"]}, {"Citation": "Kabsch W. Integration, scaling, space-group assignment and post-refinement. Acta Crystallogr. D Biol. Crystallogr. 2010;66:133\u2013144.", "ArticleIdList": ["PMC2815666", "20124693"]}, {"Citation": "Winter G., Waterman D.G., Parkhurst J.M., Brewster A.S., Gildea R.J., Gerstel M., et al. DIALS: implementation and evaluation of a new integration package. Acta Crystallogr. D Struct. Biol. 2018;74:85\u201397.", "ArticleIdList": ["PMC5947772", "29533234"]}, {"Citation": "Potterton L., Agirre J., Ballard C., Cowtan K., Dodson E., Evans P.R., et al. CCP4i2: the new graphical user interface to the CCP4 program suite. Acta Crystallogr. D Struct. Biol. 2018;74:68\u201384.", "ArticleIdList": ["PMC5947771", "29533233"]}, {"Citation": "McCoy A.J., Grosse-Kunstleve R.W., Adams P.D., Winn M.D., Storoni L.C., Read R.J. Phaser crystallographic software. J.\u00a0Appl. Crystallogr. 2007;40:658\u2013674.", "ArticleIdList": ["PMC2483472", "19461840"]}, {"Citation": "Adams P.D., Afonine P.V., Bunkoczi G., Chen V.B., Davis I.W., Echols N., et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 2010;66:213\u2013221.", "ArticleIdList": ["PMC2815670", "20124702"]}, {"Citation": "Murshudov G.N., Vagin A.A., Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 1997;53:240\u2013255.", "ArticleIdList": ["15299926"]}, {"Citation": "Emsley P., Lohkamp B., Scott W.G., Cowtan K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 2010;66:486\u2013501.", "ArticleIdList": ["PMC2852313", "20383002"]}, {"Citation": "Adasme M.F., Linnemann K.L., Bolz S.N., Kaiser F., Salentin S., Haupt V.J., et al. PLIP 2021: expanding the scope of the protein-ligand interaction profiler to DNA and RNA. Nucleic Acids Res. 2021;49:W530\u2013W534.", "ArticleIdList": ["PMC8262720", "33950214"]}, {"Citation": "Pettersen E.F., Goddard T.D., Huang C.C., Couch G.S., Greenblatt D.M., Meng E.C., et al. UCSF Chimera--a visualization system for exploratory research and analysis. J.\u00a0Comput. Chem. 2004;25:1605\u20131612.", "ArticleIdList": ["15264254"]}]}], "History": [{"Year": "2023", "Month": "10", "Day": "24"}, {"Year": "2024", "Month": "4", "Day": "8"}, {"Year": "2024", "Month": "4", "Day": "17"}, {"Year": "2024", "Month": "7", "Day": "26", "Hour": "12", "Minute": "39"}, {"Year": "2024", "Month": "5", "Day": "24", "Hour": "0", "Minute": "41"}, {"Year": "2024", "Month": "5", "Day": "23", "Hour": "19", "Minute": "27"}, {"Year": "2024", "Month": "5", "Day": "22"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38782206", "PMC11253539", "10.1016/j.jbc.2024.107358", "S0021-9258(24)01859-3"]}}]}